As of 2026-03-14, the Relative Valuation of Gemini Therapeutics Inc (GMTX) is (23.07) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.35 USD, the upside of Gemini Therapeutics Inc based on Relative Valuation is -1809.2%.
The range of the Relative Valuation is (22.48) - (24.25) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.8x - 23.8x | 21.1x |
| Forward P/E multiples | 19.7x - 22.4x | 21.6x |
| Fair Price | (22.48) - (24.25) | (23.07) |
| Upside | -1765.2% - -1896.4% | -1809.2% |
| Date | P/E |